Nyxoah Stock (NASDAQ:NYXH)
Previous Close
$1.59
52W Range
$1.26 - $8.59
50D Avg
$2.71
200D Avg
$4.20
Market Cap
$63.37M
Avg Vol (3M)
$255.29K
Beta
0.89
Div Yield
-
NYXH Company Profile
Nyxoah S.A. is a medical technology company dedicated to developing and bringing to market therapies for sleep disordered breathing conditions. Its flagship offering is the Genio system, a CE-Marked, patient-focused hypoglossal neurostimulation therapy that addresses moderate to severe obstructive sleep apnea. Established in 2009, the company maintains its headquarters in Mont-Saint-Guibert, Belgium.